Volume 4,Issue 3
Objective: To observe the effect of remote ischemic conditioning + arterial thrombolysis in patients with ultra-early cerebral infarction. Methods: 60 patients with ultra-early cerebral infarction were used as samples, and this study was carried out from April 2022 to April 2023. The patients were randomly divided into Group A and Group B. The patients in Group A received remote ischemic treatment + arterial thrombolysis, whereas the patients in Group B received arterial thrombolysis. Methods: The coagulation indicators, inflammatory factors, quality of life, and adverse reactions of both groups were compared. Results: The blood coagulation indexes of the patients in Group A were better than those in Group B (P < 0.05); the inflammation indexes in Group A were lower than those in Group B (P < 0.05); the SF-36 scores in Group A were higher than those in Group B (P < 0.05); the adverse reaction rate in patients with cerebral infarction was lower than that in Group B (P < 0.05). Conclusion: Remote ischemic conditioning + arterial thrombolysis is effective and feasible in treating patients with ultra-early cerebral infarction, and it inhibits inflammation and improves coagulation function.